Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways
R Hilker, AV Thomas, JC Klein, S Weisenbach… - Neurology, 2005 - AAN Enterprises
Neurology, 2005•AAN Enterprises
Objective: To assess neurochemical deficits in patients with Parkinson disease (PD)
associated dementia (PDD) in vivo. Methods: The authors performed combined PET with N-
[11C]-methyl-4-piperidyl acetate (MP4A) and 18F-fluorodopa (FDOPA) for evaluation of
cholinergic and dopaminergic transmitter changes in 17 non-demented patients with PD and
10 patients with PDD. Data were compared to 31 age-matched controls by a combined
region-of-interest and voxel-based Statistical Parametric Mapping analysis. Results: The …
associated dementia (PDD) in vivo. Methods: The authors performed combined PET with N-
[11C]-methyl-4-piperidyl acetate (MP4A) and 18F-fluorodopa (FDOPA) for evaluation of
cholinergic and dopaminergic transmitter changes in 17 non-demented patients with PD and
10 patients with PDD. Data were compared to 31 age-matched controls by a combined
region-of-interest and voxel-based Statistical Parametric Mapping analysis. Results: The …
Objective: To assess neurochemical deficits in patients with Parkinson disease (PD) associated dementia (PDD) in vivo.
Methods: The authors performed combined PET with N-[11C]-methyl-4-piperidyl acetate (MP4A) and 18F-fluorodopa (FDOPA) for evaluation of cholinergic and dopaminergic transmitter changes in 17 non-demented patients with PD and 10 patients with PDD. Data were compared to 31 age-matched controls by a combined region-of-interest and voxel-based Statistical Parametric Mapping analysis.
Results: The striatal FDOPA uptake was significantly decreased in PD and PDD without differences between the groups. The global cortical MP4A binding was severely reduced in PDD (29.7%, p < 0.001 vs controls) and moderately decreased in PD (10.7%, p < 0.01 vs controls). The PDD group had lower parietal MP4A uptake rates than did patients with PD. Frontal and temporo-parietal cortices showed a significant covariance of striatal FDOPA reduction and decreased MP4A binding in patients with PDD.
Conclusions: While non-demented patients with Parkinson disease had a moderate cholinergic dysfunction, subjects with Parkinson disease associated dementia (PDD) presented with a severe cholinergic deficit in various cortical regions. The finding of a closely associated striatal FDOPA and cortical MP4A binding reduction suggests a common disease process leading to a complex transmitter deficiency syndrome in PDD.
American Academy of Neurology